Direct Measurements of Endothelium-Derived Nitric Oxide Release by Stimulation of Endothelin Receptors in Rat Kidney and Its Alteration in Salt-Induced Hypertension
Authors:
- 15 February 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (4) , 1229-1235
Abstract
Background Stimulation of endothelin subtype B (ET B ) receptors has been proposed to induce release of endothelium-derived nitric oxide (EDNO). Methods and Results To obtain direct evidence of its release and its alteration in deoxycorticosterone acetate (DOCA)-salt hypertension, EDNO released from renal vessels by ET stimulation was assayed by a highly sensitive chemiluminescence method. Kidneys were isolated from DOCA-salt and control rats, and renal perfusion pressure (RPP) and EDNO (by hydrogen peroxide–luminol chemiluminescence) in the perfusate were monitored simultaneously during perfusion of ET-1, ET-3, an ET A receptor antagonist (BQ-123), and an ET B receptor agonist (BQ-3020). In control rats, ET-1 and ET-3 dose-dependently increased both RPP and NO release. Although the vasoconstricting effects of ET-1 were greater, their NO-releasing effects were comparable. The increase in NO release by ETs was inhibited by N G -monomethyl- l -arginine. After 10 −6 mol/L BQ-123 treatment, ET-1 decreased RPP and increased NO release in control kidneys. DOCA-salt rats responded to these agents with much less NO release. BQ-3020 at up to 10 −10 mol/L caused vasodilation (RPP, 10 −11 mol/L, −5.4±1.7%, P <.01) associated with increased NO release in control kidneys (+9.0±2.7 fmol · min −1 · g −1 kidney wt, P <.01). However, in DOCA-salt kidneys, BQ-3020 caused renal vasoconstriction (RPP, +5.4±2.4%, P <.01 versus control) and a much smaller NO release (+1.1±0.4 fmol · min −1 · g −1 kidney wt, P <.01 versus control). Northern blot analysis revealed that renal ET B mRNA was significantly decreased in DOCA-salt rat kidneys compared with controls (0.36±0.13 versus 1.00±0.23, P <.05). Conclusions These results suggest that ET-1 and ET-3 release EDNO via ET B receptors in renal vessels. ET B -mediated NO release was reduced in DOCA-salt rats, which may modulate renal function and thus blood pressure regulation in DOCA-salt hypertensive rats.Keywords
This publication has 42 references indexed in Scilit:
- Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.Hypertension, 1993
- Is endothelin involved in the pathogenesis of hypertension?Hypertension, 1993
- Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.Hypertension, 1993
- Calcium, phosphoinositide, and 1,2-diacylglycerol responses of blood vessels of deoxycorticosterone acetate-salt hypertensive rats to endothelin-1.Hypertension, 1992
- Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats.Hypertension, 1992
- Endothelin-1- and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxideLife Sciences, 1992
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Endothelin-3 stimulates production of endothelium-derived nitric oxide via phosphoinositide breakdownBiochemical and Biophysical Research Communications, 1991
- Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive ratsBiochemical and Biophysical Research Communications, 1990
- L-NG-monomethyl arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1990